Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$982,791
-$484,809 QoQ
Shares Held
218,398
+264.0% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026MOORE CAPITAL MANAGEMENT, LP holds $33,834,798 across 8 Diagnostics & Research names. MYGN ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ICLR |
Icon PLC
|
147,208 | $16,290,037 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
43,234 | $7,457,865 | |
| 3 | SHC |
Sotera Health Co
|
252,441 | $3,620,003 | |
| 4 | VCYT |
Veracyte, Inc.
|
79,760 | $2,569,069 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
8,097 | $1,380,862 | |
| 6 | MYGN |
Myriad Genetics Inc
This page
|
218,398 | $982,791 | |
| 7 | QGEN |
Qiagen N.V.
|
20,000 | $800,800 | |
| 8 | FLGT |
Fulgent Genetics, Inc.
|
46,124 | $733,371 |
All Filings in MYGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $982,791 | 218,398 | Shares | Sole | 2026-05-15 | |
| 2024-06-30 | $1,467,600 | 60,000 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||